Release Date: 30/08/12 13:28 Summary: Preliminary Final Report Price Sensitive: Yes Download Document 337.85KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%